Optimize safety and purity testing in your cell therapy workflow

Cell therapies must adhere to high standards of safety, purity and quality. However, testing for contamination in these therapies can be challenging due to short shelf lives and the inability to use traditional sterilization techniques on live‑cell therapeutics. Thermo Fisher Scientific’s Applied Biosystems portfolio of assay kits for mycoplasma and sterility testing deliver innovative solutions to help ensure product safety and purity.

Read this application note to learn more about:

• Meeting the challenges of product safety testing for complex CAR‑T cell therapies
• Comparison of molecular-based testing methods against traditional growth-based methods
• Strategies to enhance the safety, quality, and regulatory compliance of cell therapy products through optimized testing protocols

MycoSEQ™ Plus Mycoplasma Detection Systems - Actionable, same-day results to help ensure mycoplasma-free biotherapeutics Product page Link

SteriSEQ™ Sterility Testing Assay – Accelerate cell therapy manufacturing with simple, rapid sterility testing Product page Link